Orphapacket:
  AverageAgeOfOnsets:
    AverageAgeOfOnset:
    - value: Childhood
  Childs:
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '714'
            Source: HGNC
          - Reference: '611542'
            Source: OMIM
          Label: arylsulfatase B
          Symbol: ARSB
      Label: Mucopolysaccharidosis type 6, rapidly progressing
      ORPHAcode: '276212'
  - Child:
      Genes:
      - Gene:
          DisorderGeneAssociationType: Disease-causing germline mutation(s) in
          ExternalReferences:
          - Reference: '714'
            Source: HGNC
          - Reference: '611542'
            Source: OMIM
          Label: arylsulfatase B
          Symbol: ARSB
      Label: Mucopolysaccharidosis type 6, slowly progressing
      ORPHAcode: '276223'
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - DisorderMappingRelation: 'E (Exact mapping: the two concepts are equivalent)'
    Reference: '253200'
    Source: OMIM
  Label: Mucopolysaccharidosis type 6
  ORPHAcode: '583'
  ORPHApacketId: '583'
  PURL: http://www.orpha.net/ORDO/Orphanet_583
  Parents:
  - Parent:
    - Label: Mucopolysaccharidosis
      ORPHAcode: '79213'
  - Parent:
    - Label: Lysosomal storage disease with skeletal involvement
      ORPHAcode: '93448'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000179
      HPOTerm: Thick lower lip vermilion
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000246
      HPOTerm: Sinusitis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000280
      HPOTerm: Coarse facial features
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000389
      HPOTerm: Chronic otitis media
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000944
      HPOTerm: Abnormal metaphysis morphology
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001387
      HPOTerm: Joint stiffness
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001508
      HPOTerm: Failure to thrive
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002656
      HPOTerm: Epiphyseal dysplasia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002788
      HPOTerm: Recurrent upper respiratory tract infections
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0003521
      HPOTerm: Disproportionate short-trunk short stature
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0007759
      HPOTerm: Opacification of the corneal stroma
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0008155
      HPOTerm: Mucopolysacchariduria
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0009928
      HPOTerm: Thick nasal alae
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000365
      HPOTerm: Hearing impairment
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000470
      HPOTerm: Short neck
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000885
      HPOTerm: Broad ribs
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001744
      HPOTerm: Splenomegaly
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002808
      HPOTerm: Kyphosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002857
      HPOTerm: Genu valgum
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003300
      HPOTerm: Ovoid vertebral bodies
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0100790
      HPOTerm: Hernia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000158
      HPOTerm: Macroglossia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000505
      HPOTerm: Visual impairment
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001654
      HPOTerm: Abnormal heart valve morphology
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002564
      HPOTerm: Malformation of the heart and great vessels
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0030680
      HPOTerm: Abnormality of cardiovascular system morphology
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0100543
      HPOTerm: Cognitive impairment
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: ORPHANET
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Germany
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 16435194[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 10480370[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Portugal
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 14685153[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 18681890[PMID]_25274184[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Sweden
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18681890[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 18681890[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Norway
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18681890[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 18681890[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 18681890[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Czech Republic
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 20490927[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 16600651[PMID]_14608657[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 10617747[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Taiwan, Province of China
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 19396827[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Estonia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 22480138[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Colombia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22550061[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: European Medicines Agency 2001[INST]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Turkey
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 16435194[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Poland
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 25472774[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Saudi Arabia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 20622343[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Brazil
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 'PMID: 31926052'
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Japan
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 28595941[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Switzerland
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 28595941[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: Tunisia
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 20209839[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: Korea, Republic of
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 25364648[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Prevalence at birth
      Source: 34051828[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: <1 / 1 000 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 34051828[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: ARSB deficiency
  - Synonym: ASB deficiency
  - Synonym: Arylsulfatase B deficiency
  - Synonym: MPS6
  - Synonym: MPSVI
  - Synonym: Maroteaux-Lamy disease
  - Synonym: Mucopolysaccharidosis type VI
  - Synonym: N-acetylgalactosamine 4-sulfatase deficiency
  TextSection:
    Contents: Mucopolysaccharidosis type 6 (MPS 6) is a lysosomal storage disease
      with progressive multisystem involvement associated with a deficiency of arylsulfatase
      B (ASB) leading to the accumulation of dermatan sulfate.
    TextSectionType: Definition
  TypeOfInheritances:
    TypeOfInheritance:
    - value: Autosomal recessive
  copyright: Orphanet (c) 2024
  creationDate: '2024-07-01 09:48:26'
  version: 1.3.29 / 4.1.7 [2023-08-02] (orientdb version)
